13 Stocks Under $5 With High Upside Potential

Page 12 of 12

1. ImmunityBio Inc. (NASDAQ:IBRX)

Stock Price: $2.72

Analyst Upside: 194.12%

Number of Hedge Fund Holders: 10

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 13 Stocks Under $5 With High Upside Potential. ImmunityBio Inc. (NASDAQ:IBRX) announced on June 2 that the US Food and Drug Administration, FDA, granted Expanded Access authorization for its Cancer BioShield platform, anchored by ANKTIVA, for the treatment of lymphopenia. Lymphopenia is a life-threatening immune deficiency induced by radiotherapy, chemotherapy, and immunotherapy.

Following the announcement, H.C. Wainwright analyst Andres Y. Maldonado maintained a Buy rating on ImmunityBio Inc. (NASDAQ:IBRX) on June 4 and set a price target of $8.00. The analyst reasoned that the Cancer BioShield platform and the company’s therapies hold the potential to address immune collapse in complex cancer cases, bringing a positive light to its operations.

ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat cancer and infectious diseases. Its immunotherapy platform activates the adaptive and innate immune systems to create long-term immunological memory.

While we acknowledge the potential of IBRX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IBRX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 12 of 12